Physician profile
Jeffrey Fair
NPI 1780606004
$14,221.72
in general payments reported to CMS, 2019-2025
6 companies · $53.05 in 2025
The $53.05 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $14.93 · 2023: $1,500 · 2024: $15.74 · 2025: $53.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $68.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $68.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spark Therapeutics, INC. | $12,638.00 | 2019 | |
| Intuitive Surgical, INC. | $1,500.00 | 2023 | Davinci Xi |
| Madrigal Pharmaceuticals | $29.53 | 2025 | Rezdiffra |
| Smith+Nephew, INC. | $23.52 | 2025 | Oasis, Grafix Pl, Stravix |
| Tela Bio, INC. | $15.74 | 2024 | Ovitex 2s |
| Veloxis Pharmaceuticals, INC. | $14.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Fair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.